A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

United States

Cahaba Derm and skin hlth ctr 27, Birmingham, Alabama

Clinical Trials Research Institute, Thousand Oaks, California

Miami Derm and Laser Institute, Miami, Florida

Dawes Fretzin Clinical Rea Group, Indianapolis, Indiana

Revival Research Institute, Troy, Michigan

Austin Inst for Clinical Research, Pflugerville, Texas

Australia

Novartis Investigative Site, Sydney, New South Wales

Novartis Investigative Site, Waitara, New South Wales

Canada

Novartis Investigative Site, Mississauga, Ontario

Novartis Investigative Site, Toronto, Ontario